Site Search

... will be making the following fact-based policies a priority and ask for your support :      Ensuring Access to Quality Care   Access to Biomarker Testing: ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...

... Cancer Action Network (ACS CAN)   COLUMBUS, OHIO – “Today, the House Insurance Committee passed legislation that would increase access to biomarker testing. This legislation will help address a significant barrier and bring the promise of precision medicine to more Ohioans, no matter their income or where they live. Biomarker testing opens the door to targeted therapies, which can provide many benefits to patients, including better outcomes, improved quality of ...

... director: “To improve access to care for those who hear the words 'you have cancer,' ACS CAN calls on the legislature to increase access to biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments by ensuring state-regulated health insurance, including Medicaid, covers appropriate biomarker testing for patients who could benefit. Dubbed ‘the right treatment at the right time,’ precision medicine has played a critical role ...

... passed legislation that will improve access to care for cancer patients by making out-of-pocket costs more predictable and expand coverage for biomarker testing.  HB1745 will make prescription drug expenses more predictable by requiring health insurance carriers to offer more health plans with flat ... to their local pharmacy and being shocked by their monthly prescription costs. Separately, HB1799 will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine treatments. Dubbed ‘the right treatment, to the right patient, at the right ...